Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC5056 Tch-013

Non-competitive modulator of the proteasome inducing apoptosis a panel of myeloma and leukemia cell lines

1132091-17-8
DCC5057 Tc-i 2000

Novel TRPM8 channel blocker

1150006-20-9
DCC5058 Tc-i 2014

Potent TRPM8 antagonist, exhibiting antiallodynic properties in pain models

1221349-53-6
DCC5059 tcmdc-125802

Antimalarial; Novel inhibitor of HepG2

1060-19-1
DCC5060 Tcmdc-135051 Tfa Salt

Novel Inhibitor of the malaria parasite protein kinase CLK3, inhibiting the development of liver-stage parasites, killing asexual blood-stage parasites at the trophozoite and schizont stages of the erythrocytic cycle, blocking the development of sexual ga

2413716-15-9
DCC5061 Tcn-237 Dihydrochloride

Highly potent NR2B-selective NMDA receptor antagonist

700878-19-9
DCC5062 Tc-ot-39

Nonpeptide partial agonist of oxytocin (OT) and vasopressin V2 receptors

479232-57-0
DCC5063 Tc-s 7005

Potent and selective polo-like kinase 2 (PLK2) inhibitor

1082739-92-1
DCC5064 Tcs2312

Novel potent and selective CHK1 kinase inhibitor

838823-31-7
DCC5065 Tcs2314

Novel Integrin very late antigen-4 (VLA-4; α4β1) antagonist, blocking the activation of inflammatory cells.

317353-73-4
DCC5066 Tcs-3035

Novel GPR35 agonist

871085-49-3
DCC5067 Tcs-401

Insulin receptor sensitizing agent; Selective inhibitor of protein-tyrosine phosphatase 1B (PTP1B)

243967-42-2
DCC5068 Tc-t 6000

Potent equilibrative nucleoside transporter 4 (ENT4) inhibitor

949467-71-4
DCC5069 T-cupm

Sorafenib analogue, retaining cytotoxicity similar to sorafenib in various human cancer cell lines and strongly inhibiting growth in the NCI-60 cell line panel

DCC5070 Td-004

Novel degrader of the anaplastic lymphoma kinase (ALK) fusion protein, effectively inducing ALK degradation and inhibiting the growth of ALK fusion positive cell lines, SU-DHL-1 and H3122, significantly reducing the tumor growth in H3122 xenograft model

DCC5071 Td-106

Novel IKZF1/3 degrader, inhibiting the proliferation of multiple myeloma cells in vitro as well as in vivo

2250288-69-6
DCC5072 Td-1211

Novel selective opioid receptor antagonist at all three receptor types

949904-48-7
DCC5073 Td-428

Novel potent BET protein degrader, inhibiting cell proliferation due to suppressed C-MYC transcription

2334525-50-5
DCC5074 Td-5471 Hydrochloride

Novel long-acting β 2 -adrenoceptor agonist

530084-35-6
DCC5075 Tdcipp

Hepatotoxicity inducer, significantly up-regulating the expression of genes involved in endoplasmic reticulum stress and Toll-like receptor (TLR) pathway

13674-87-8
DCC5076 Tdmq20

Novel Specific Copper Chelator, Reducing Memory Impairments in Alzheimer's Disease Mouse Models

DCC5077 Tdp1-in-9a

Novel potent inhibitor of tyrosyl-DNA phosphodiesterase 1 (Tdp1)

Page 1452 / Total 1558 FirstPrevNextLastGoto